US Public Data LabU.S. public data, made readable
Data areas
Federal Register Congress bills CISA KEV / NVD SEC EDGAR USAspending Defense contracts Trade Economy Energy Places FDA recalls AI Research Grants NIH research grants Fiscal & national debt
Tools
Search Recent Rankings Compare Money flows Timeline Compare indicators Topics
Profiles
Company profiles Agency profiles Glossary Contact
EN▾
日本語 English
Class II Medical Device Z-2590-2026 Ongoing

Unapproved design changes in syringe kits (Z-2590-2026) — the reason is not a fault in the product but a departure from what was cleared

Medline Industries, LP ・Reported Jul 1, 2026

Medical convenience kits containing syringes recalled because design changes were made outside what the agency had cleared. The firm identified this in an internal review, covering 113,843 kits.

Recall overview (primary data)

  • ClassificationClass II
  • Product typeMedical Device
  • Recalling firmMedline Industries, LP
  • ReasonFirm identified unapproved design changes to the products outside of the 510(k) cleared by the FDA. Products not initially reported in RES 98601.
  • DistributionUS Nationwide distribution including in the states of AL, AR, AZ, CA, CO, CT, FL, GA, IL, KS, KY, LA, MA, MD, MI, MN, MO, MS, MT, NE, NJ, NM, NV, NY, OH, OK, OR, PA, RI, TN, TX, VA, WI, WY and the c...
  • Recall initiated2026-02-27

Key points

  • Medical convenience kits containing syringes were recalled for design changes made outside what the agency had cleared.
  • The reason is not a fault in performance or safety but that the product and what was cleared do not match.
  • The firm identified it in an internal review, and products not covered by an earlier report were added to scope.
  • Initiation was February 27, 2026 and the report date July 1, an interval of more than four months.
  • Where one component within a kit is at issue the whole kit falls within scope, with scope traced from component supply to finished goods.

1What was found wanting

The reason is not that the product is broken or contaminated. It is that the design was changed outside what the agency had cleared. What was submitted and cleared differs from what is actually being made, and that divergence is itself the reason.

Where performance or safety is at faultWhere clearance was departed from (this case)
Using the product produces a faultThe product may work as intended, but that has not been confirmed
The cause lies in design or manufactureThe cause lies in procedure
Remedy means correcting the productRemedy means resubmitting or returning to the cleared design

Medical devices reach the market through a submission showing substantial equivalence to a device already cleared. This site covers that submission route and its classification separately. What was cleared is what was submitted; departing from it removes the basis on which clearance rested.

2The firm found it itself

  1. 1Internal reviewThe firm compares its products against what it submitted
  2. 2DiscoveryIt identifies changes falling outside the cleared scope
  3. 3Report and recallIt reports to the agency and initiates a recall
  4. 4AdditionProducts not covered by an earlier submission are brought into scope

The record states that the firm identified this through an internal review, and that products not included in an earlier report were added. That a recall does not end with one report, and that its scope can widen afterwards, is worth holding in mind when reading these records.

3The interval from initiation to report

Recall initiatedFebruary 27, 2026Initiated voluntarily by the firm
Report dateJuly 1, 2026More than four months later
Quantity113,843 kitsCovering syringes contained in the kits

Initiation on February 27 and a report date of July 1 leave a gap of more than four months. Among the records this site holds as of 2026-09-04, two weeks to a month is more usual, making this a long interval. It may relate to the scope widening afterwards, though the record gives no reason.

4The form of a kit

The products are convenience kits assembling several items. Where one component within a kit is at issue, the whole kit falls within scope. The records this site holds include kits brought into scope because they contained a recalled component, showing how scope is set by tracing the path from component supply to finished goods.

Why it matters

For devices, the match between what was cleared and what is made is itself the regulated object. Without a step checking each design change against the cleared scope, a recall can follow even where performance is sound.

FAQ

Can a recall occur without a fault?
Yes. Devices are sold on the basis of what was submitted and cleared, so changing the design outside that scope removes the basis for clearance.
Does the scope of a recall change?
In this record, products not included in an earlier report were added. A recall does not always end with one report.

Related explainers

Sources (primary)

Source: openFDA (U.S. FDA, CC0 public domain). Data is provided as-is and must not be used for medical decisions. Verify the latest and exact details with the official FDA recall information. This site is not endorsed or certified by the U.S. FDA.

#FDA#Recalls#Medical devices#Design changes#Premarket notification

← Back to FDA recall alerts

Disclaimer: This site independently summarizes and classifies information based on official data sources. Always verify the latest and accurate information with the official sources. Content on finance, health, legal, and security is information, not advice. This site is not an official website of the U.S. government.